701 related articles for article (PubMed ID: 19564559)
1. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J
Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559
[TBL] [Abstract][Full Text] [Related]
2. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
3. VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus.
Waltenberger J
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1167-70. PubMed ID: 19909240
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
[TBL] [Abstract][Full Text] [Related]
5. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt.
Kim SH; Juhnn YS; Kang S; Park SW; Sung MW; Bang YJ; Song YS
Cell Mol Life Sci; 2006 Apr; 63(7-8):930-8. PubMed ID: 16596339
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I
Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
[TBL] [Abstract][Full Text] [Related]
10. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.
List AF; Glinsmann-Gibson B; Stadheim C; Meuillet EJ; Bellamy W; Powis G
Exp Hematol; 2004 Jun; 32(6):526-35. PubMed ID: 15183893
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor protects hepatoma cells against oxidative stress-induced cell death.
Osada S; Imai H; Tomita H; Tokuyma Y; Okumura N; Sakashita F; Nonoka K; Sugiyama Y
J Gastroenterol Hepatol; 2006 Jun; 21(6):988-93. PubMed ID: 16724983
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane.
Chang X; Firestone GL; Bjeldanes LF
Carcinogenesis; 2006 Mar; 27(3):541-50. PubMed ID: 16199440
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
16. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
Kou B; Ni J; Vatish M; Singer DR
Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways.
Sun C; Liang C; Ren Y; Zhen Y; He Z; Wang H; Tan H; Pan X; Wu Z
Basic Res Cardiol; 2009 Jan; 104(1):42-9. PubMed ID: 18622638
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes.
Tchaikovski V; Fellbrich G; Waltenberger J
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):322-8. PubMed ID: 18079407
[TBL] [Abstract][Full Text] [Related]
19. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.
Sasso FC; Torella D; Carbonara O; Ellison GM; Torella M; Scardone M; Marra C; Nasti R; Marfella R; Cozzolino D; Indolfi C; Cotrufo M; Torella R; Salvatore T
J Am Coll Cardiol; 2005 Sep; 46(5):827-34. PubMed ID: 16139132
[TBL] [Abstract][Full Text] [Related]
20. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.
Caron C; Spring K; Laramée M; Chabot C; Cloutier M; Gu H; Royal I
Cell Signal; 2009 Jun; 21(6):943-53. PubMed ID: 19233262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
